Effect of the codon 72 polymorphism (c.215G>C, p.Arg72Pro) in combination with somatic sequence variants in the TP53 gene on survival in patients with advanced ovarian carcinoma†
Yun Wang
Department of Gynecologic Oncology, The Norwegian Radium Hospital, Oslo, Norway
Department of Genetics, The Norwegian Radium Hospital, Oslo, Norway
Search for more papers by this authorPedro Kringen
Department of Genetics, The Norwegian Radium Hospital, Oslo, Norway
Search for more papers by this authorGunnar B. Kristensen
Department of Gynecologic Oncology, The Norwegian Radium Hospital, Oslo, Norway
Search for more papers by this authorRuth Holm
Department of Pathology, The Norwegian Radium Hospital, Oslo, Norway
Search for more papers by this authorMark M.O. Baekelandt
Department of Gynecologic Oncology, The Norwegian Radium Hospital, Oslo, Norway
Search for more papers by this authorMagali Olivier
International Agency for Research on Cancer (CIRC/IARC), Lyon, France
Search for more papers by this authorHanne Skomedal
Department of Pathology, The Norwegian Radium Hospital, Oslo, Norway
Search for more papers by this authorPierre Hainaut
International Agency for Research on Cancer (CIRC/IARC), Lyon, France
Search for more papers by this authorClaes G. Tropé
Department of Genetics, The Norwegian Radium Hospital, Oslo, Norway
Search for more papers by this authorVera M. Abeler
Department of Pathology, The Norwegian Radium Hospital, Oslo, Norway
Search for more papers by this authorJahn M. Nesland
Department of Pathology, The Norwegian Radium Hospital, Oslo, Norway
Search for more papers by this authorCorresponding Author
Anne-Lise Børresen-Dale
Department of Genetics, The Norwegian Radium Hospital, Oslo, Norway
Department of Genetics, The Norwegian Radium Hospital, N-0310, Oslo, NorwaySearch for more papers by this authorÅslaug Helland
Department of Genetics, The Norwegian Radium Hospital, Oslo, Norway
Department of Oncology, The Norwegian Radium Hospital, Oslo, Norway
Search for more papers by this authorYun Wang
Department of Gynecologic Oncology, The Norwegian Radium Hospital, Oslo, Norway
Department of Genetics, The Norwegian Radium Hospital, Oslo, Norway
Search for more papers by this authorPedro Kringen
Department of Genetics, The Norwegian Radium Hospital, Oslo, Norway
Search for more papers by this authorGunnar B. Kristensen
Department of Gynecologic Oncology, The Norwegian Radium Hospital, Oslo, Norway
Search for more papers by this authorRuth Holm
Department of Pathology, The Norwegian Radium Hospital, Oslo, Norway
Search for more papers by this authorMark M.O. Baekelandt
Department of Gynecologic Oncology, The Norwegian Radium Hospital, Oslo, Norway
Search for more papers by this authorMagali Olivier
International Agency for Research on Cancer (CIRC/IARC), Lyon, France
Search for more papers by this authorHanne Skomedal
Department of Pathology, The Norwegian Radium Hospital, Oslo, Norway
Search for more papers by this authorPierre Hainaut
International Agency for Research on Cancer (CIRC/IARC), Lyon, France
Search for more papers by this authorClaes G. Tropé
Department of Genetics, The Norwegian Radium Hospital, Oslo, Norway
Search for more papers by this authorVera M. Abeler
Department of Pathology, The Norwegian Radium Hospital, Oslo, Norway
Search for more papers by this authorJahn M. Nesland
Department of Pathology, The Norwegian Radium Hospital, Oslo, Norway
Search for more papers by this authorCorresponding Author
Anne-Lise Børresen-Dale
Department of Genetics, The Norwegian Radium Hospital, Oslo, Norway
Department of Genetics, The Norwegian Radium Hospital, N-0310, Oslo, NorwaySearch for more papers by this authorÅslaug Helland
Department of Genetics, The Norwegian Radium Hospital, Oslo, Norway
Department of Oncology, The Norwegian Radium Hospital, Oslo, Norway
Search for more papers by this authorThe publisher regrets the long delay in publication of the erratum.
